WORLD HEALTH ORGANIZATION UPDATES EMERGENCY USE LISTING FOR NOVAVAX NUVAXOVID COVID-19 VACCINE AS A PRIMARY SERIES IN ADOLESCENTS AND AS A BOOSTER IN ADULTS News WORLD HEALTH ORGANIZATION UPDATES EMERGENCY USE LISTING FOR NOVAVAX NUVAXOVID COVID-19 VACCINE AS A PRIMARY SERIES IN ADOLESCENTS AND AS A BOOSTER IN ADULTS By Zalika Famaceutica|2022-11-30T11:32:28-03:00novembro 29, 2022|News|